|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:escitalopram
|
|
gptkbp:approvedBy
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_Kingdom
2002
|
|
gptkbp:ATCCode
|
N06AB10
|
|
gptkbp:brand
|
gptkb:escitalopram
|
|
gptkbp:contraindication
|
concomitant use with MAOIs
|
|
gptkbp:drugClass
|
selective serotonin reuptake inhibitor
|
|
gptkbp:eliminatedIn
|
urine
feces
|
|
gptkbp:form
|
gptkb:tablet
oral drops
|
|
gptkbp:genericAvailable
|
yes
|
|
gptkbp:halfLife
|
27-32 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cipralex
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Lundbeck
|
|
gptkbp:marketedAs
|
gptkb:Lexapro
gptkb:Seroplex
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
gptkb:C_(Australia)
|
|
gptkbp:prescribes
|
adults
adolescents (in some countries)
|
|
gptkbp:prescriptionRequired
|
yes
|
|
gptkbp:relatedTo
|
gptkb:citalopram
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
fatigue
insomnia
dry mouth
sexual dysfunction
increased sweating
|
|
gptkbp:usedFor
|
gptkb:generalized_anxiety_disorder
gptkb:obsessive-compulsive_disorder
gptkb:panic_disorder
gptkb:social_anxiety_disorder
gptkb:major_depressive_disorder
|
|
gptkbp:bfsParent
|
gptkb:escitalopram
gptkb:Lundbeck
gptkb:H._Lundbeck_A/S
gptkb:H_Lundbeck
gptkb:Escitalopram
|
|
gptkbp:bfsLayer
|
7
|